Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals
M Butler - Applied microbiology and biotechnology, 2005 - Springer
There has been a rapid increase in the number and demand for approved
biopharmaceuticals produced from animal cell culture processes over the last few years. In …
biopharmaceuticals produced from animal cell culture processes over the last few years. In …
Cancer immunotherapy
M Schuster, A Nechansky… - Biotechnology Journal …, 2006 - Wiley Online Library
Cancer is the second leading cause of death in the industrialized world. Most cancer
patients are treated by a combination of surgery, radiation and/or chemotherapy. Whereas …
patients are treated by a combination of surgery, radiation and/or chemotherapy. Whereas …
Suspendable hydrogel nanovials for massively parallel single-cell functional analysis and sorting
Techniques to analyze and sort single cells based on functional outputs, such as secreted
products, have the potential to transform our understanding of cellular biology as well as …
products, have the potential to transform our understanding of cellular biology as well as …
Polynucleotides encoding anti-CD20 antigen binding molecules with increased Fc receptor binding affinity and effector function
P Umana, P Brünker, CF Koller, T Suter… - US Patent …, 2016 - Google Patents
The present invention relates to nucleic acids encoding anti-CD20 antigen binding
molecules (ABMs). In particular embodiments, the present invention relates to nucleic acid …
molecules (ABMs). In particular embodiments, the present invention relates to nucleic acid …
Stabilized gene duplication enables long-term selection-free heterologous pathway expression
KEJ Tyo, PK Ajikumar, G Stephanopoulos - Nature biotechnology, 2009 - nature.com
Engineering robust microbes for the biotech industry typically requires high-level, genetically
stable expression of heterologous genes and pathways. Although plasmids have been used …
stable expression of heterologous genes and pathways. Although plasmids have been used …
Optimized signal peptides for the development of high expressing CHO cell lines
L Kober, C Zehe, J Bode - Biotechnology and bioengineering, 2013 - Wiley Online Library
Recombinant biotherapeutic proteins such as monoclonal antibodies are mostly produced in
Chinese hamster ovary (CHO) cells and pharmaceutical companies are interested in an …
Chinese hamster ovary (CHO) cells and pharmaceutical companies are interested in an …
Selection methods for high-producing mammalian cell lines
SM Browne, M Al-Rubeai - Trends in biotechnology, 2007 - cell.com
The selection of high-producing mammalian cell lines represents a bottleneck in process
development for the production of biopharmaceuticals. Traditional methods are time …
development for the production of biopharmaceuticals. Traditional methods are time …
Intraclonal protein expression heterogeneity in recombinant CHO cells
W Pilbrough, TP Munro, P Gray - PloS one, 2009 - journals.plos.org
Therapeutic glycoproteins have played a major role in the commercial success of
biotechnology in the post-genomic era. But isolating recombinant mammalian cell lines for …
biotechnology in the post-genomic era. But isolating recombinant mammalian cell lines for …
Effect of increased expression of protein disulfide isomerase and heavy chain binding protein on antibody secretion in a recombinant CHO cell line
N Borth, D Mattanovich, R Kunert… - Biotechnology …, 2005 - Wiley Online Library
Previous work has shown that a human‐antibody‐producing recombinant CHO cell line did
not increase its intracellular content of protein disulfide isomerase (PDI) and heavy chain …
not increase its intracellular content of protein disulfide isomerase (PDI) and heavy chain …
An'omics approach towards CHO cell engineering
P Datta, RJ Linhardt… - Biotechnology and …, 2013 - Wiley Online Library
Chinese hamster ovarian cells (CHO) cells have been extensively utilized for industrial
production of biopharmaceutical products, such as monoclonal antibodies, human growth …
production of biopharmaceutical products, such as monoclonal antibodies, human growth …